Economic and quality of life consequences of clinically important deterioration in patients with COPD: results from the TORCH study

A. Ismaila (Collegeville, PA, United States of America), M. Driessen (Brentford, United Kingdom), A. Briggs (Glasgow, Scotland, United Kingdom), N. Risebrough (Toronto, ON, Canada), I. Naya (Brentford, United Kingdom), N. Gunsoy (Stockley Park, Uxbridge, United Kingdom), V. Paly (Philadelphia, PA, United States of America)

Source: International Congress 2018 – Clinical trials in COPD: new results
Session: Clinical trials in COPD: new results
Session type: Oral Presentation
Number: 1660
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ismaila (Collegeville, PA, United States of America), M. Driessen (Brentford, United Kingdom), A. Briggs (Glasgow, Scotland, United Kingdom), N. Risebrough (Toronto, ON, Canada), I. Naya (Brentford, United Kingdom), N. Gunsoy (Stockley Park, Uxbridge, United Kingdom), V. Paly (Philadelphia, PA, United States of America). Economic and quality of life consequences of clinically important deterioration in patients with COPD: results from the TORCH study. 1660

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: